|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: ALBANY MOLECULAR RESEARCH INC, 10-Q, 2000-08-14 |
Next: AREMISSOFT CORP /DE/, 10-Q, 2000-08-14 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 12,292
<SECURITIES> 16,911
<RECEIVABLES> 6,207
<ALLOWANCES> 110
<INVENTORY> 1,118
<CURRENT-ASSETS> 46,007
<PP&E> 25,911
<DEPRECIATION> 5,202
<TOTAL-ASSETS> 102,376
<CURRENT-LIABILITIES> 6,241
<BONDS> 0
0
0
<COMMON> 297
<OTHER-SE> 95,838
<TOTAL-LIABILITY-AND-EQUITY> 102,376
<SALES> 16,667
<TOTAL-REVENUES> 30,092
<CGS> 9,324
<TOTAL-COSTS> 10,577
<OTHER-EXPENSES> 4,755
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 6
<INCOME-PRETAX> 16,365
<INCOME-TAX> 6,086
<INCOME-CONTINUING> 10,279
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 10,279
<EPS-BASIC> 0.35
<EPS-DILUTED> 0.33
</TABLE>
|
|